2019Chin J Cell Stem Cell (Electronic Edition)Requires access

Effect of TLR4 on LPS-induced bronchial epithelial 16HBE cell injury

Guangfu Shen, Changqin Luo, Bo Huang, Jing Bi, Xuan Zhang, Rui Yu, Jun Yang, Jun Xie

Open publisher page 0 citations

Abstract

Objective To investigate the effect of TLR4 on LPS-induced bronchial epithelial 16HBE cell injury and its mechanism. Methods Three siRNA-TLR4-1, siRNA-TLR4-2 and siRNA-TLR4-3 were transfected into 16HBE cells, and the best interference sequence was screened for experiment. The experiment was divided into a control group (untreated) , LPS group (treated with 50 μg/ml LPS) , LPS + siNC group (treated with 50 μg/mL LPS after transfection of siRNA- NC) and LPS + siTLR4 group (treated with 50 μg/ml LPS after transfection of siRNA-TLR4) . The expression of TLR4, IL-6 and TNF-α was detected by RT-PCR, cell viability was detected by MTT, apoptotic rate was detected by flow cytometry, and the expression of Bcl-2, Bax, Cleaved Caspase- 3, NF-κBp65 and IκBα proteins were tested by Western Blot. One-way analysis of variance was used for comparison between groups. SNK-q was used for multiple comparisons between groups, and independent sample t test was used for comparison between the two groups. Results The TLR4 mRNA (2.05±0.12 vs 3.28±0.15) and protein expression (0.38±0.03 vs 0.77±0.05) in the LPS group and the LPS+siTLR4-2 group were statistically significant (t = 11.091, 11.585, P 0.05) . Conclusion Downregulation of TLR4 can alleviate 16HBE cell injury by inhibiting activation of NF-κB pathway, inhibiting LPS-induced apoptosis and inflammation. Key words: Toll-like Receptor 4; Lipopolysaccharide; Bronchial epithelial cells;  Inflammation; Apoptosis

About this research paper

What this paper is about

Objective To investigate the effect of TLR4 on LPS-induced bronchial epithelial 16HBE cell injury and its mechanism. Methods Three siRNA-TLR4-1, siRNA-TLR4-2 and siRNA-TLR4-3 were transfected into 16HBE cells, and the best interference sequence was screened for experiment. The experiment was divided into a control group (untreated) , LPS group (treated with 50 μg/ml LPS) , LPS + siNC group (treated with 50 μg/mL LPS after transfection of siRNA- NC) and LPS + siTLR4 group (treated with 50 μg/ml LPS after transfection of siRNA-TLR4) . The expression of TLR4, IL-6 and TNF-α was detected by RT-PCR, cell viability was detected by MTT, apoptotic rate was detected by flow cytometry, and the expression of Bcl-2, Bax, Cleaved Caspase- 3, NF-κBp65 and IκBα proteins were tested by Western Blot. One-way analysis of variance was used for comparison between groups. SNK-q was used for multiple comparisons between groups, and independent sample t test was used for comparison between the two groups. Results The TLR4 mRNA (2.05±0.12 vs 3.28±0.15) and protein expression (0.38±0.03 vs 0.77±0.05) in the LPS group and the LPS+siTLR4-2 group were statistically significant (t = 11.091, 11.585, P 0.05) . Conclusion Downregulation of TLR4 can alleviate 16HBE cell injury by inhibiting activation of NF-κB pathway, inhibiting LPS-induced apoptosis and inflammation. Key words: Toll-like Receptor 4; Lipopolysaccharide; Bronchial epithelial cells;  Inflammation; Apoptosis

Why it matters

A significance statement is not available in the OpenAlex record.

Key contribution

A contribution statement is not available in the OpenAlex record.

Method / approach

Method details are not available in the OpenAlex metadata.

Main findings

Findings are not separately available in the OpenAlex metadata.

Limitations

Limitations are not available in the OpenAlex metadata.

Applications

Application details are not available in the OpenAlex metadata.

Available abstract

Objective To investigate the effect of TLR4 on LPS-induced bronchial epithelial 16HBE cell injury and its mechanism. Methods Three siRNA-TLR4-1, siRNA-TLR4-2 and siRNA-TLR4-3 were transfected into 16HBE cells, and the best interference sequence was screened for experiment. The experiment was divided into a control group (untreated) , LPS group (treated with 50 μg/ml LPS) , LPS + siNC group (treated with 50 μg/mL LPS after transfection of siRNA- NC) and LPS + siTLR4 group (treated with 50 μg/ml LPS after transfection of siRNA-TLR4) . The expression of TLR4, IL-6 and TNF-α was detected by RT-PCR, cell viability was detected by MTT, apoptotic rate was detected by flow cytometry, and the expression of Bcl-2, Bax, Cleaved Caspase- 3, NF-κBp65 and IκBα proteins were tested by Western Blot. One-way analysis of variance was used for comparison between groups. SNK-q was used for multiple comparisons between groups, and independent sample t test was used for comparison between the two groups. Results The TLR4 mRNA (2.05±0.12 vs 3.28±0.15) and protein expression (0.38±0.03 vs 0.77±0.05) in the LPS group and the LPS+siTLR4-2 group were statistically significant (t = 11.091, 11.585, P 0.05) . Conclusion Downregulation of TLR4 can alleviate 16HBE cell injury by inhibiting activation of NF-κB pathway, inhibiting LPS-induced apoptosis and inflammation. Key words: Toll-like Receptor 4; Lipopolysaccharide; Bronchial epithelial cells;  Inflammation; Apoptosis

Key concepts: TLR4, Apoptosis, Transfection, Western blot, Lipopolysaccharide, Molecular biology, Chemistry, Flow cytometry

Related papers

Back to paper searchBrowse research topicsOriginal source
Effect of TLR4 on LPS-induced bronchial epithelial 16HBE cell injury — Research Paper | ScholarLens